VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: SpaceX's Rocky Unlock Is a Warning for OpenAI
Value Add VC/Pulse/IPOBY THE NUMBERS

SpaceX's Rocky Unlock Is a Warning for OpenAI

SpaceX shares are trading near $108, down more than half from their post-IPO high, just as the first of four straight monthly unlock events begins -- a live case study for OpenAI and Anthropic on what happens once lockups start expiring.

By the Numbers

$225+
SpaceX post-IPO high
~$108
Current price
>50%
Drawdown from peak
3 (Aug 20, Sept, Oct)
Unlocks remaining
$965B
Anthropic Jun valuation
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
August 6, 2026
1 min read
ShareXLinkedInEmail
TC

The VC Read · Trace's Take

Trace Cohen

SpaceX's post-IPO drawdown is happening in real time while OpenAI and Anthropic are still in the confidential-filing stage -- that's a live pricing lesson both companies' bankers are watching closely, whether they say so publicly or not. The specific number I'd track: how SpaceX trades through September's ~700M-share unlock, because that's the closest available proxy for what a clean OpenAI or Anthropic debut actually has to survive a year from now, not just on IPO day.

Tech IPO Tracker → AI Valuations Tracker →

Analysis

SpaceX is the closest live comparable OpenAI and Anthropic have for what happens after a trillion-dollar-adjacent private company goes public, and the early read isn't encouraging. SpaceX priced its IPO in June, popped to $150 on debut, ran past $225 within days, and closed this week at $108.27, according to CNBC -- a drawdown of more than 50% from the post-IPO peak, arriving the same week as the first of four consecutive monthly share-unlock events that will roughly double, then keep expanding, the stock's public float through October.

The mechanism is straightforward: a stock that traded on scarcity while insiders were locked up gets tested every time a new, large batch of sellable shares hits the market, and SpaceX's first unlock -- 911.5 million shares, up to $116 billion -- landed while the stock was already trading well off its highs, not from strength. Pulse covered the unlock itself in detail; this is about what it means for the two companies watching closest.

“Pulse covered the unlock itself in detail; this is about what it means for the two companies watching closest.”

That sequencing matters for Anthropic and OpenAI specifically. Anthropic priced its last private round at a $965 billion valuation in June and has an IPO roadshow already underway; OpenAI has filed confidentially and carries a similar order-of-magnitude private mark, with SoftBank alone committing roughly $64.6 billion toward it. Both companies will eventually face their own version of SpaceX's August: a period where paper valuation meets a public order book and early backers get their first real chance to sell.

None of this predicts how OpenAI or Anthropic will trade -- different company, different investor base, different lockup structures are all live variables. But it does mean anyone modeling a clean, straight-line path from "confidential S-1 filed" to "stock holds its private mark" should look at what four straight months of unlock events are currently doing to the most comparable mega-IPO available.

ShareXLinkedInEmail

More on

SpaceX →Anthropic →OpenAI →

Reported by Value Add Pulse Analysis · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 7, 2026

SpaceX Swings From Post-Earnings Drop to 16% Rally

Illustration for: SpaceX Swings From Post-Earnings Drop to 16% Rally
IPO$7.81B Q2 revenue

SpaceX Swings From Post-Earnings Drop to 16% Rally

SpaceX stock fell 8% after a Q2 earnings beat spooked investors on capex, then rallied 15.83% three days later as its first lockup expiration passed without heavy selling and the Cursor deal stayed on track.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

IPO· Aug 7, 2026

BofA's Sell Signal Hits Highest Level Since 2021

Illustration for: BofA's Sell Signal Hits Highest Level Since 2021
IPO

BofA's Sell Signal Hits Highest Level Since 2021

Bank of America's Bull & Bear sentiment indicator jumped to 9.7 -- its highest reading since 2021 and above the firm's own 8.0 sell-signal threshold -- even as the S&P 500 and Nasdaq both rallied Friday on weak jobs data.

@Trace_Cohen·t@nyvp.com